Literature DB >> 6277901

1,25-Dihydroxyvitamin D3 receptors and functions in cultured pig kidney cells (LLC PK1). Regulation of 24,25-dihydroxyvitamin D3 production.

K Colston, D Feldman.   

Abstract

Although 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) regulates the renal metabolism of 25-hydroxyvitamin D3 (25-OH-D3), the mechanism is not well understood. The established pig kidney cell line, LLC PK1, was used to study this feedback regulation. These cells possess a receptor for 1,25-(OH)2D3 with a sedimentation coefficient of 3.2 S. Scatchard analysis of 1,25-(OH)2D3 binding to cell cytosol yielded an apparent Kd of 0.12 nM and an Nmax of 26 fmol/mg of cytosol protein. LLC PK1 cells respond to 1,25-(OH)2D3 by changes in the metabolism of 25-OH-D3. When incubated with 25-OH-[3H]D3, homogenates of untreated cells did not produce detectable 1,25-(OH)2[3H]D3 or 24,25-(OH)2[3H]D3. However, after treatment of cell monolayers with 1,25-(OH)2D3 for 8 h, homogenates converted substantial 25-OH-[3H]D2 substrate to 24,25-(OH)2[3H]D3. The appearance of this 24-hydroxylase activity in response to 1,25-(OH)2D3 was time- and dose-dependent. Half-maximal levels of enzyme activity were achieved with 0.13 nM 1,25-(OH)2D3, a concentration almost identical to the Kd of the 1,25-(OH)2D3 receptor. The stimulation of 24-hydroxylase activity was shown to be an induction event; treatment of monolayers with 13 nM 1,25-(OH)2D3 for a 4-h pulse was sufficient to induce maximal activity assayed at h. The presence of the transcriptional inhibitor, actinomycin D, during the 4-h pulse abolished the induction of 24-hydroxylase activity. These results demonstrate for the first time the presence of both 1,25-(OH)2D3 receptors and stimulation of 24-hydroxylase activity within the same established mammalian kidney cell line.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6277901

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  The molecular basis of hereditary 1,25-dihydroxyvitamin D3 resistant rickets in seven related families.

Authors:  P J Malloy; Z Hochberg; D Tiosano; J W Pike; M R Hughes; D Feldman
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

2.  Two siblings with vitamin-D-dependent rickets type II: no recurrence of rickets for 14 years after cessation of therapy.

Authors:  E Takeda; I Yokota; I Kawakami; T Hashimoto; Y Kuroda; S Arase
Journal:  Eur J Pediatr       Date:  1989-10       Impact factor: 3.183

3.  Two mutations in the hormone binding domain of the vitamin D receptor cause tissue resistance to 1,25 dihydroxyvitamin D3.

Authors:  K Kristjansson; A R Rut; M Hewison; J L O'Riordan; M R Hughes
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

4.  Clinical and biochemical findings in parents of children with vitamin D-dependent rickets Type II.

Authors:  I Yokota; E Takeda; M Ito; H Kobashi; T Saijo; Y Kuroda
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

5.  Production of C-24- and C-23-oxidized metabolites of 1,25-dihydroxycholecalciferol by cultured kidney cells (LLC PK1) and their presence in kidney in vivo.

Authors:  J L Napoli; C A Martin
Journal:  Biochem J       Date:  1984-05-01       Impact factor: 3.857

6.  Local action of phosphate depletion and insulin-like growth factor 1 on in vitro production of 1,25-dihydroxyvitamin D by cultured mammalian kidney cells.

Authors:  L Condamine; C Menaa; F Vrtovsnik; F Vztovsnik; G Friedlander; M Garabédian
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

7.  Vitamin D-dependent rickets type II. Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 1,25-dihydroxyvitamin D3 in cultured skin fibroblasts.

Authors:  G T Gamblin; U A Liberman; C Eil; R W Downs; D A DeGrange; S J Marx
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

8.  Chronic 1,25-dihydroxyvitamin D3 administration in the rat reduces the serum concentration of 25-hydroxyvitamin D by increasing metabolic clearance rate.

Authors:  B P Halloran; D D Bikle; M J Levens; M E Castro; R K Globus; E Holton
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

9.  Impaired stimulation of 25-hydroxyvitamin D-24-hydroxylase in fibroblasts from a patient with vitamin D-dependent rickets, type II. A form of receptor-positive resistance to 1,25-dihydroxyvitamin D3.

Authors:  J E Griffin; J E Zerwekh
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

10.  Dexamethasone enhances vitamin D-24-hydroxylase expression in osteoblastic (UMR-106) and renal (LLC-PK1) cells treated with 1alpha,25-dihydroxyvitamin D3.

Authors:  Izuru Kurahashi; Ayako Matsunuma; Tetsuya Kawane; Masatoshi Abe; Noboru Horiuchi
Journal:  Endocrine       Date:  2002-03       Impact factor: 3.925

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.